Company Profile

SuperArray Bioscience Corporation
Profile last edited on: 12/14/06      CAGE: 3KTW6      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1998
First Award
2003
Latest Award
2009
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7320 Executive Way Suite 101
Frederick, MD 21704
   (301) 682-9200
   support@superarray.net
   www.superarray.net
Location: Single
Congr. District: 06
County: Frederick

Public Profile

SuperArray Bioscience Corporation is a privately held biotechnology company. focused to developing a new, more systematic approach to biological research in the post-genomic era. The firm has a portfolio of research tools that merge the benefits of hypothesis-driven and discovery-based research. SuperArray Bioscience develops and markets a broad range of innovative and cost-effective research tools based on absolutely current knowledge and understanding of important biological pathways. All of our products are organized into pathway-focused kits. Our goal is always to provide practical research tools that accelerate, simplify and improve life science research. SuperArray's gene array products, RNA interference products, and PCR products are complementary research tools by design. This powerful tool set forms an integrated platform for the systematic study of a single gene, or an entire collection of genes, on a pathway-by-pathway basis. The planned gene overlap among the three sets of tools accelerates the study of important disease state and cell function pathways. Organizing genes into pathway-specific kits provides our customers with several unique advantages: * simplified planning of research projects * quicker, more efficient execution of research projects * lower overall cost of experimentation.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2009 1 NIH $150,225
Project Title: Contract #n43-Co-95012-616 Months Funding -Phase 1 Topic 265 Development Of Shrn
2003 1 NIH $162,841
Project Title: Multiplexed Analysis of Protein Tyrosine Kinases
2003 1 NIH $171,200
Project Title: ID-Tag Protein Profiling Array for the Molecular Charact

Key People / Management

  Li Shen -- President

  Qing X Yang

  Sean Yu

  Xiao Zeng

Company News

There are no news available.